| ISSN: 1139-8736 Depósito Legal: B-37271-2002 Copyright: © Silvia Montero Martínez |
|
N
|
Word
|
Freq.
|
|
1220
|
STRUCTURES |
45
|
|
1221
|
SUBTYPES |
45
|
|
1222
|
SUGGESTED |
45
|
|
1223
|
VASCULAR |
45
|
|
1224
|
VISUAL |
45
|
|
1225
|
WHOM |
45
|
|
1226
|
AA |
44
|
|
1227
|
DEMONSTRATE |
44
|
|
1228
|
DISTAL |
44
|
|
1229
|
ESOPHAGUS |
44
|
|
1230
|
EVENT |
44
|
|
1231
|
EXTENDS |
44
|
|
1232
|
FIGO |
44
|
|
1233
|
HOSPITAL |
44
|
|
1234
|
LARYNX |
44
|
|
1235
|
NECROSIS |
44
|
|
1236
|
OOPHORECTOMY |
44
|
|
1237
|
ORGANIZATION |
44
|
|
1238
|
PEREZ |
44
|
|
1239
|
PLEURAL |
44
|
|
1240
|
PRESENTING |
44
|
|
1241
|
PROVIDE |
44
|
|
1242
|
RANGE |
44
|
|
1243
|
RESULTED |
44
|
|
1244
|
SEE |
44
|
|
1245
|
SLOW |
44
|
|
1246
|
SUBSTANTIAL |
44
|
|
1247
|
TJ |
44
|
|
1248
|
ADVERSE |
43
|
|
1249
|
ASSESSMENT |
43
|
|
1250
|
BIOLOGICAL |
43
|
|
1251
|
DF |
43
|
|
1252
|
ENTIRE |
43
|
|
1253
|
EPENDYMOMAS |
43
|
|
1254
|
FEW |
43
|
|
1255
|
FILE |
43
|
|
1256
|
GE |
43
|
|
1257
|
GROUPINGS |
43
|
|
1258
|
HD |
43
|
|
1259
|
INITIALLY |
43
|
|
1260
|
INTRACAVITARY |
43
|
|
1261
|
INTRAOPERATIVE |
43
|
|
1262
|
MASSIVE |
43
|
|
1263
|
NONCLEAVED |
43
|
|
1264
|
OPERATION |
43
|
|
1265
|
PROTOCOLS |
43
|
|
1266
|
PT |
43
|
|
1267
|
RATHER |
43
|
|
1268
|
SEQUENTIAL |
43
|
|
1269
|
SIDE |
43
|
|
1270
|
TOMOGRAPHIC |
43
|
|
1271
|
VISCERAL |
43
|
|
1272
|
BILIARY |
42
|
|
1273
|
CHARACTERIZED |
42
|
|
1274
|
CLOSED |
42
|
|
1275
|
DELAY |
42
|
|
1276
|
DEPTH |
42
|
|
1277
|
DYSGERMINOMA |
42
|
|
1278
|
EMPLOYED |
42
|
|
1279
|
EYE |
42
|
|
1280
|
GERMAN |
42
|
|
1281
|
HOROWITZ |
42
|
|
1282
|
INSTITUTION |
42
|
|
1283
|
INTENSIFICATIO+ |
42
|
|
1284
|
INTRATHECAL |
42
|
|
1285
|
JG |
42
|
|
1286
|
LINEAGE |
42
|
|
1287
|
LITTLE |
42
|
|
1288
|
MANAGED |
42
|
|
1289
|
MESNA |
42
|
|
1290
|
PRODUCED |
42
|
|
1291
|
ROUTINE |
42
|
|
1292
|
SCHEDULES |
42
|
|
1293
|
ANDROGEN |
41
|
|
1294
|
AXILLARY |
41
|
|
1295
|
CS |
41
|
|
1296
|
EXCEPT |
41
|
|
1297
|
EXTRANODAL |
41
|
|
1298
|
HJ |
41
|
|
1299
|
INTRAVESICAL |
41
|
|
1300
|
MARGIN |
41
|
|
1301
|
MC |
41
|
|
1302
|
NSABP |
41
|
|
1303
|
OBJECTIVE |
41
|
|
1304
|
ORDER |
41
|
|
1305
|
PENIS |
41
|
|
1306
|
PK |
41
|
|
1307
|
PREVENT |
41
|
|
1308
|
PREVIOUS |
41
|
|
1309
|
PROMYELOCYTIC |
41
|
|
1310
|
REDUCE |
41
|
|
1311
|
REGARDLESS |
41
|
|
1312
|
RETINOIC |
41
|
|
1313
|
SOLITARY |
41
|
|
1314
|
TONGUE |
41
|
|
1315
|
TUMOURS |
41
|
|
1316
|
UNDERGO |
41
|
|
1317
|
UNFAVORABLE |
41
|
|
1318
|
WORKING |
41
|
|
1319
|
ABNORMAL |
40
|
|
1320
|
ACQUIRED |
40
|
|
1321
|
CONJUNCTION |
40
|
|
1322
|
CYTOTOXIC |
40
|
|
1323
|
DAYS |
40
|
|
1324
|
DESIGNATED |
40
|
|
1325
|
DETECTION |
40
|
|
1326
|
EC |
40
|
|
1327
|
ESSENTIAL |
40
|
|
1328
|
ESTABLISHED |
40
|
|
1329
|
LIKELIHOOD |
40
|
|
1330
|
NATURAL |
40
|
|
1331
|
NEOPLASM |
40
|
|
1332
|
PENILE |
40
|
|
1333
|
POORER |
40
|
|
1334
|
PRETREATMENT |
40
|
|
1335
|
REMOVED |
40
|
|
1336
|
SC |
40
|
|
1337
|
SYSTEMS |
40
|
|
1338
|
TEN |
40
|
|
1339
|
TESTIS |
40
|
|
1340
|
UVEAL |
40
|
|
1341
|
AE |
39
|
|
1342
|
AFP |
39
|
|
1343
|
BEP |
39
|
|
1344
|
CONSULT |
39
|
|
1345
|
DC |
39
|
|
1346
|
DEVELOPING |
39
|
|
1347
|
DIVIDED |
39
|
|
1348
|
DONOR |
39
|
|
1349
|
ER |
39
|
|
1350
|
EXPERTISE |
39
|
|
1351
|
FAMILIAL |
39
|
|
1352
|
FINAL |
39
|
|
1353
|
HAVING |
39
|
|
1354
|
HLA |
39
|
|
1355
|
IMMUNOGLOBULIN |
39
|
|
1356
|
IMPLANTATION |
39
|
|
1357
|
INVOLVE |
39
|
|
1358
|
IRINOTECAN |
39
|
|
1359
|
MULTIVARIATE |
39
|
|
1360
|
PERIOD |
39
|
|
1361
|
PM |
39
|
|
1362
|
PRE |
39
|
|
1363
|
REPRESENT |
39
|
|
1364
|
RG |
39
|
|
1365
|
RH |
39
|
|
1366
|
SO |
39
|
|
1367
|
SPLENIC |
39
|
|
1368
|
ST |
39
|
|
1369
|
STUDIED |
39
|
|
1370
|
SUCCESSFUL |
39
|
|
1371
|
SUTTON |
39
|
|
1372
|
THEN |
39
|
|
1373
|
TOMOGRAPHY |
39
|
|
1374
|
WEEKLY |
39
|
|
1375
|
WORLD |
39
|
|
1376
|
ARISING |
38
|
|
1377
|
AVOID |
38
|
|
1378
|
BCG |
38
|
|
1379
|
BIOCHEMICAL |
38
|
|
1380
|
CHEMORADIOTHER+ |
38
|
|
1381
|
CHLORODEOXYADE+ |
38
|
|
1382
|
CHOROID |
38
|
|
1383
|
CONSENSUS |
38
|
|
1384
|
CONTROVERSIAL |
38
|
|
1385
|
DETECTABLE |
38
|
|
1386
|
DIAPHRAGM |
38
|
|
1387
|
ENUCLEATION |
38
|
|
1388
|
FINE |
38
|
|
1389
|
GALLBLADDER |
38
|
|
1390
|
GJ |
38
|
|
1391
|
IIIB |
38
|
|
1392
|
INTENSITY |
38
|
|
1393
|
IVB |
38
|
|
1394
|
LEAD |
38
|
|
1395
|
MARKER |
38
|
|
1396
|
MECHLORETHAMIN+ |
38
|
|
1397
|
METHOD |
38
|
|
1398
|
MODERATELY |
38
|
|
1399
|
NEEDLE |
38
|
|
1400
|
OPERATIVE |
38
|
|
1401
|
PARTICULAR |
38
|
|
1402
|
SENSITIVE |
38
|
|
1403
|
SINUSES |
38
|
|
1404
|
SPLEEN |
38
|
|
1405
|
SPLENECTOMY |
38
|
|
1406
|
STAGED |
38
|
|
1407
|
SURVIVORS |
38
|
|
1408
|
TAXOL |
38
|
|
1409
|
ULTRASOUND |
38
|
|
1410
|
UPDATE |
38
|
|
1411
|
AP |
37
|
|
1412
|
CANAL |
37
|
|
1413
|
CC |
37
|
|
1414
|
ENTRY |
37
|
|
1415
|
EVANS |
37
|
|
1416
|
EXAMINED |
37
|
|
1417
|
EXPECTED |
37
|
|
1418
|
EXTRAGONADAL |
37
|
|
1419
|
FEASIBLE |
37
|
|
1420
|
FERTILITY |
37
|
|
1421
|
FIELDS |
37
|
|
1422
|
HYDROXYUREA |
37
|
|
1423
|
HYPOTHALAMIC |
37
|
|
1424
|
INDICATIONS |
37
|
|
1425
|
LIP |
37
|
|
1426
|
MEDULLARY |
37
|
|
1427
|
MT |
37
|
|
1428
|
NEUROLOGIC |
37
|
|
1429
|
NEUTRON |
37
|
|
1430
|
NJ |
37
|
|
1431
|
OUTLINED |
37
|
|
1432
|
PATHOLOGICAL |
37
|
|
1433
|
RW |
37
|
|
1434
|
SP |
37
|
|
1435
|
STROMAL |
37
|
|
1436
|
SUBTYPE |
37
|
|
1437
|
TRANSLOCATION |
37
|
|
1438
|
UNDERGOING |
37
|
|
1439
|
AC |
36
|
|
1440
|
ACCELERATED |
36
|
|
1441
|
ADENOCARCINOMA+ |
36
|
|
1442
|
AGAINST |
36
|
|
1443
|
ALVEOLAR |
36
|
|
1444
|
BASAL |
36
|
|
1445
|
CAUSES |
36
|
|
1446
|
CORRELATION |
36
|
|
1447
|
CRITICAL |
36
|
|
1448
|
DAUNORUBICIN |
36
|
|
1449
|
FA |
36
|
|
1450
|
FISHER |
36
|
|
1451
|
FLUDARABINE |
36
|
|
1452
|
HEMATOLOGIC |
36
|
|
1453
|
INTERLEUKIN |
36
|
|
1454
|
INTRAPERITONEA+ |
36
|
|
1455
|
ISLET |
36
|
|
1456
|
MATCHED |
36
|
|
1457
|
MEANS |
36
|
|
1458
|
MRI |
36
|
|
1459
|
NX |
36
|
|
1460
|
RAY |
36
|
|
1461
|
STATISTICALLY |
36
|
|
1462
|
STIMULATING |
36
|
|
1463
|
VENA |
36
|
|
1464
|
WH |
36
|
|
1465
|
WK |
36
|
|
1466
|
ARMS |
35
|
|
1467
|
ATRA |
35
|
|
1468
|
BASE |
35
|
|
1469
|
BJ |
35
|
|
1470
|
CL |
35
|
|
1471
|
CMF |
35
|
|
1472
|
COUNCIL |
35
|
|
1473
|
DELIVERED |
35
|
|
1474
|
DISTINCT |
35
|
|
1475
|
EFFECTIVENESS |
35
|
|
1476
|
INFECTIONS |
35
|
|
1477
|
LARYNGEAL |
35
|
|
1478
|
ONCOLOGISTS |
35
|
|
1479
|
REGARDING |
35
|
|
1480
|
REHABILITATION |
35
|
|
1481
|
SUBCUTANEOUS |
35
|
|
1482
|
THICKNESS |
35
|
|
1483
|
TREAT |
35
|
|
1484
|
WBC |
35
|
|
1485
|
WHITE |
35
|
|
1486
|
ANTIBODY |
34
|
|
1487
|
BRENNAN |
34
|
|
1488
|
CB |
34
|
|
1489
|
CHOROIDAL |
34
|
|
1490
|
COMPARE |
34
|
|
1491
|
CONSECUTIVE |
34
|
|
1492
|
COUNTS |
34
|
|
1493
|
CUP |
34
|
|
1494
|
DISCUSSION |
34
|
|
1495
|
DOUGLASS |
34
|
|
1496
|
ENTITY |
34
|
|
1497
|
EXAMPLE |
34
|
|
1498
|
GRAFT |
34
|
|
1499
|
INCREASING |
34
|
|
1500
|
INTENT |
34
|
|
1501
|
MATURE |
34
|
|
1502
|
OLIGODENDROGLI+ |
34
|
|
1503
|
OTHERS |
34
|
|
1504
|
PEB |
34
|
|
1505
|
RADIOSENSITIZE+ |
34
|
|
1506
|
RECENT |
34
|
|
1507
|
SALPINGO |
34
|
|
1508
|
SEZARY |
34
|
|
1509
|
SPHINCTER |
34
|
|
1510
|
STOMACH |
34
|
|
1511
|
STRATEGIES |
34
|
|
1512
|
SUPPORT |
34
|
|
1513
|
TYPICALLY |
34
|
|
1514
|
URETER |
34
|
|
1515
|
VAC |
34
|
|
1516
|
VARIABLES |
34
|
|
1517
|
ALMOST |
33
|
|
1518
|
CATEGORIES |
33
|
|
1519
|
CHEMORADIATION |
33
|
|
1520
|
CONTINUED |
33
|
|
1521
|
CP |
33
|
|
1522
|
CRYOSURGERY |
33
|
|
1523
|
DEPENDENT |
33
|
|
1524
|
DONORS |
33
|
|
1525
|
DYSFUNCTION |
33
|
|
1526
|
EINHORN |
33
|
|
1527
|
EPSTEIN |
33
|
|
1528
|
FM |
33
|
|
1529
|
HA |
33
|
|
1530
|
IL |
33
|
|
1531
|
LE |
33
|
|
1532
|
MX |
33
|
|
1533
|
NONMETASTATIC |
33
|
|
1534
|
NONRHABDOMYOSA+ |
33
|
|
1535
|
PERCUTANEOUS |
33
|
|
1536
|
PRECURSOR |
33
|
|
1537
|
PREDICTIVE |
33
|
|
1538
|
PROPHYLAXIS |
33
|
|
1539
|
PW |
33
|
|
1540
|
RECOMBINANT |
33
|
|
1541
|
STRONG |
33
|
|
1542
|
SUBSET |
33
|
|
1543
|
TIMES |
33
|
|
1544
|
AFFECT |
32
|
|
1545
|
ALONG |
32
|
|
1546
|
CONCOMITANT |
32
|
|
1547
|
CONTRAST |
32
|
|
1548
|
CYTOLOGY |
32
|
|
1549
|
DEPEND |
32
|
|
1550
|
DOCUMENTED |
32
|
|
1551
|
ESTROGEN |
32
|
|
1552
|
FEMALE |
32
|
|
1553
|
GRANULOCYTE |
32
|
|
1554
|
MASTECTOMY |
32
|
|
1555
|
MODULATION |
32
|
|
1556
|
O'CONNELL |
32
|
|
1557
|
PALATE |
32
|
|
1558
|
PORTAL |
32
|
|
1559
|
PREDOMINANT |
32
|
|
1560
|
RAPID |
32
|
|
1561
|
RELATIONSHIP |
32
|
|
1562
|
SAMPLING |
32
|
|
1563
|
SE |
32
|
|
1564
|
TERATOMAS |
32
|
|
1565
|
TR |
32
|
|
1566
|
VARIABLE |
32
|
|
1567
|
WA |
32
|
|
1568
|
CAPSULE |
31
|
|
1569
|
CAUSED |
31
|
|
1570
|
CERTAIN |
31
|
|
1571
|
CF |
31
|
|
1572
|
DEEP |
31
|
|
1573
|
EXPERIENCED |
31
|
|
1574
|
FR |
31
|
|
1575
|
GOG |
31
|
|
1576
|
GR |
31
|
|
1577
|
HCG |
31
|
|
1578
|
HELPFUL |
31
|
|
1579
|
HISTOPATHOLOGI+ |
31
|
|
1580
|
IDENTIFICATION |
31
|
|
1581
|
IMMUNOHISTOCHE+ |
31
|
|
1582
|
INDUCED |
31
|
|
1583
|
ISOTRETINOIN |
31
|
|
1584
|
KANTARJIAN |
31
|
|
1585
|
LACK |
31
|
|
1586
|
LYMPHOCYTES |
31
|
|
1587
|
MILLION |
31
|
|
1588
|
PATHWAY |
31
|
|
1589
|
PG |
31
|
|
1590
|
RAPIDLY |
31
|
|
1591
|
SAUNDERS |
31
|
|
1592
|
SG |
31
|
|
1593
|
TRANSURETHRAL |
31
|
|
1594
|
WP |
31
|
|
1595
|
AR |
30
|
|
1596
|
BECKWITH |
30
|
|
1597
|
BFM |
30
|
|
1598
|
CI |
30
|
|
1599
|
CML |
30
|
|
1600
|
COLONY |
30
|
|
1601
|
COMPLETION |
30
|
|
1602
|
CRANIOPHARYNGI+ |
30
|
|
1603
|
CUBIC |
30
|
|
1604
|
DETECT |
30
|
|
1605
|
DIRECTLY |
30
|
|
1606
|
EJ |
30
|
|
1607
|
EMBOLIZATION |
30
|
|
1608
|
FINDING |
30
|
|
1609
|
FJ |
30
|
|
1610
|
FUSION |
30
|
|
1611
|
FUTURE |
30
|
|
1612
|
GEMCITABINE |
30
|
|
1613
|
HEMATOPOIETIC |
30
|
|
1614
|
IMPROVEMENTS |
30
|
|
1615
|
INTRAEPITHELIA+ |
30
|
|
1616
|
INTRAOCULAR |
30
|
|
1617
|
LEE |
30
|
|
1618
|
MODERATE |
30
|
|
1619
|
NEEDED |
30
|
|
1620
|
NEUROENDOCRINE |
30
|
|
1621
|
OPTIC |
30
|
|
1622
|
OTOLARYNGOLOGY |
30
|
|
1623
|
PLACEBO |
30
|
|
1624
|
PLOIDY |
30
|
|
1625
|
PREDICT |
30
|
|
1626
|
RK |
30
|
|
1627
|
SUBGROUPS |
30
|
|
1628
|
SUFFICIENT |
30
|
|
1629
|
SURGEON |
30
|
|
1630
|
UNRELATED |
30
|
|
1631
|
VEIN |
30
|
|
1632
|
ABDOMEN |
29
|
|
1633
|
ABSOLUTE |
29
|
|
1634
|
ABV |
29
|
|
1635
|
AK |
29
|
|
1636
|
ALKYLATING |
29
|
|
1637
|
ALLOW |
29
|
|
1638
|
BETA |
29
|
|
1639
|
BW |
29
|
|
1640
|
CENTIMETER |
29
|
|
1641
|
CLEARLY |
29
|
|
1642
|
CUNNINGHAM |
29
|
|
1643
|
CYTOGENETICS |
29
|
|
1644
|
DP |
29
|
|
1645
|
DTIC |
29
|
|
1646
|
EQUAL |
29
|
|
1647
|
FOLLOWS |
29
|
|
1648
|
FOUR |
29
|
|
1649
|
GREEN |
29
|
|
1650
|
HARRISON |
29
|
|
1651
|
HYBRID |
29
|
|
1652
|
IMMUNE |
29
|
|
1653
|
IMMUNOPHENOTYP+ |
29
|
|
1654
|
IMMUNOSUPPRESS+ |
29
|
|
1655
|
INSTITUTES |
29
|
|
1656
|
INSTITUTIONS |
29
|
|
1657
|
INTESTINE |
29
|
|
1658
|
LED |
29
|
|
1659
|
LIGHT |
29
|
|
1660
|
LOBECTOMY |
29
|
|
1661
|
LOCATED |
29
|
|
1662
|
MDS |
29
|
|
1663
|
MILLIMETER |
29
|
|
1664
|
MONITORING |
29
|
|
1665
|
MUTATIONS |
29
|
|
1666
|
MYC |
29
|
|
1667
|
NODULAR |
29
|
|
1668
|
OCCASIONAL |
29
|
|
1669
|
ONCE |
29
|
|
1670
|
ONCOLOGIST |
29
|
|
1671
|
OVARIES |
29
|
|
1672
|
PERSISTENT |
29
|
|
1673
|
PHYSICAL |
29
|
|
1674
|
POSTREMISSION |
29
|
|
1675
|
PR |
29
|
|
1676
|
PROGESTERONE |
29
|
|
1677
|
PUVA |
29
|
|
1678
|
REGIONS |
29
|
|
1679
|
RELAPSING |
29
|
|
1680
|
SUCCESS |
29
|
|
1681
|
SUCCESSFULLY |
29
|
|
1682
|
TEST |
29
|
|
1683
|
TESTED |
29
|
|
1684
|
TOPOTECAN |
29
|
|
1685
|
VERA |
29
|
|
1686
|
ADRIAMYCIN |
28
|
|
1687
|
AERODIGESTIVE |
28
|
|
1688
|
AMPLIFICATION |
28
|
|
1689
|
AMPUTATION |
28
|
|
1690
|
ATTEMPT |
28
|
|
1691
|
ATTEMPTED |
28
|
|
1692
|
AVAILABILITY |
28
|
|
1693
|
BLAST |
28
|
|
1694
|
CARRIED |
28
|
|
1695
|
CH |
28
|
|
1696
|
CHANGES |
28
|
|
1697
|
CHROMOSOMAL |
28
|
|
1698
|
CLOSE |
28
|
|
1699
|
COLLABORATIVE |
28
|
|
1700
|
CONSISTENT |
28
|
|
1701
|
DISORDERS |
28
|
|
1702
|
EBV |
28
|
|
1703
|
EPIDEMIC |
28
|
|
1704
|
EXPOSURE |
28
|
|
1705
|
EXTRAHEPATIC |
28
|
|
1706
|
EXTRAMEDULLARY |
28
|
|
1707
|
EXTREMITIES |
28
|
|
1708
|
FAILED |
28
|
|
1709
|
FAILURES |
28
|
|
1710
|
FEVER |
28
|
|
1711
|
INFERIOR |
28
|
|
1712
|
INFUSIONAL |
28
|
|
1713
|
IRS |
28
|
|
1714
|
LINK |
28
|
|
1715
|
MIDLINE |
28
|
|
1716
|
NSCLC |
28
|
|
1717
|
NUMBERS |
28
|
|
1718
|
PHYSICIAN |
28
|
|
1719
|
PRESERVE |
28
|
|
1720
|
PROBLEMS |
28
|
|
1721
|
PROPORTION |
28
|
|
1722
|
PROXIMAL |
28
|
|
1723
|
REFERRED |
28
|
|
1724
|
RELAPSES |
28
|
|
1725
|
RESPECTIVELY |
28
|
|
1726
|
SHUSTER |
28
|
|
1727
|
SIGNS |
28
|
|
1728
|
STATEMENT |
28
|
|
1729
|
SUBTOTAL |
28
|
|
1730
|
TRANSFUSIONS |
28
|
|
1731
|
WR |
28
|
|
1732
|
ADENOPATHY |
27
|
|
1733
|
ANTIBODIES |
27
|
|
1734
|
CONFIRMATION |
27
|
|
1735
|
DEBULKING |
27
|
|
1736
|
DEFINITION |
27
|
|
1737
|
DELIVERY |
27
|
|
1738
|
DEXAMETHASONE |
27
|
|
1739
|
DISCUSSED |
27
|
|
1740
|
DURABLE |
27
|
|
1741
|
ELEMENTS |
27
|
|
1742
|
ENDOSCOPIC |
27
|
|
1743
|
EPIDERMOID |
27
|
|
1744
|
EXCESS |
27
|
|
1745
|
EXPLORING |
27
|
|
1746
|
EXTRALYMPHATIC |
27
|
|
1747
|
FAB |
27
|
|
1748
|
FLUID |
27
|
|
1749
|
GL |
27
|
|
1750
|
GLANDS |
27
|
|
1751
|
GUERIN |
27
|
|
1752
|
HYPOPHARYNGEAL |
27
|
|
1753
|
IDENTIFY |
27
|
|
1754
|
IMPLANTS |
27
|
|
1755
|
INDEPENDENT |
27
|
|
1756
|
INDEX |
27
|
|
1757
|
INDICATE |
27
|
|
1758
|
INTRA |
27
|
|
1759
|
KD |
27
|
|
1760
|
LABORATORY |
27
|
|
1761
|
LATTER |
27
|
|
1762
|
LOEHRER |
27
|
|
1763
|
MALES |
27
|
|
1764
|
MESODERMAL |
27
|
|
1765
|
MILLIMETERS |
27
|
|
1766
|
MORPHOLOGIC |
27
|
|
1767
|
PARENCHYMAL |
27
|
|
1768
|
PILOCYTIC |
27
|
|
1769
|
PL |
27
|
|
1770
|
RECENTLY |
27
|
|
1771
|
RISKS |
27
|
|
1772
|
SELECTIVE |
27
|
|
1773
|
SHORTER |
27
|
|
1774
|
SUMMARIES |
27
|
|
1775
|
TAYLOR |
27
|
|
1776
|
TRANSPLANTS |
27
|
|
1777
|
TRUE |
27
|
|
1778
|
VARY |
27
|
|
1779
|
WHENEVER |
27
|
|
1780
|
ADDED |
26
|
|
1781
|
ADOLESCENCE |
26
|
|
1782
|
AG |
26
|
|
1783
|
ALWAYS |
26
|
|
1784
|
BERLIN |
26
|
|
1785
|
BORDERLINE |
26
|
|
1786
|
BRESLOW |
26
|
|
1787
|
CHILD |
26
|
|
1788
|
COHEN |
26
|
|
1789
|
COMPARATIVE |
26
|
|
1790
|
COMPLICATION |
26
|
|
1791
|
CONFERENCE |
26
|
|
1792
|
DERMATOLOGY |
26
|
|
1793
|
DESPITE |
26
|
|
1794
|
DUKES |
26
|
|
1795
|
ELDERLY |
26
|
|
1796
|
ENDOCRINOLOGY |
26
|
|
1797
|
ENSURE |
26
|
|
1798
|
FAMILIES |
26
|
|
1799
|
GEHAN |
26
|
|
1800
|
GENETICS |
26
|
|
1801
|
GENITOURINARY |
26
|
|
1802
|
HOUR |
26
|
|
1803
|
HR |
26
|
|
1804
|
INITIATION |
26
|
|
1805
|
IODINE |
26
|
|
1806
|
LARYNGOSCOPE |
26
|
|
1807
|
LATER |
26
|
|
1808
|
LEUKEMIAS |
26
|
|
1809
|
LN |
26
|
|
1810
|
METAPLASIA |
26
|
|
1811
|
MITOTANE |
26
|
|
1812
|
MULTI |
26
|
|
1813
|
MULTIFOCAL |
26
|
|
1814
|
NE |
26
|
|
1815
|
PALPABLE |
26
|
|
1816
|
PATIENT'S |
26
|
|
1817
|
PENTOSTATIN |
26
|
|
1818
|
RATIO |
26
|
|
1819
|
RECONSTRUCTION |
26
|
|
1820
|
SB |
26
|
|
1821
|
SCHEDULE |
26
|
|
1822
|
SCORE |
26
|
|
1823
|
SIBLING |
26
|
|
1824
|
SURGEONS |
26
|
|
1825
|
THROMBOCYTOPEN+ |
26
|
|
1826
|
TRANSLOCATIONS |
26
|
|
1827
|
TREATABLE |
26
|
|
1828
|
VA |
26
|
|
1829
|
VESSELS |
26
|
|
1830
|
WF |
26
|
|
1831
|
WILSON |
26
|
|
1832
|
ACTA |
25
|
|
1833
|
ANESTHESIA |
25
|
|
1834
|
BARR |
25
|
|
1835
|
CALMETTE |
25
|
|
1836
|
CARDIOVASCULAR |
25
|
|
1837
|
CHORIOCARCINOM+ |
25
|
|
1838
|
CLINIC |
25
|
|
1839
|
CLL |
25
|
|
1840
|
COMPARABLE |
25
|
|
1841
|
COMPONENT |
25
|
|
1842
|
CONCEPTS |
25
|
|
1843
|
CONDUCTED |
25
|
|
1844
|
DATABASE |
25
|
|
1845
|
DIRECTED |
25
|
|
1846
|
DRAINAGE |
25
|
|
1847
|
DW |
25
|
|
1848
|
END |
25
|
|
1849
|
EXTRACRANIAL |
25
|
|
1850
|
EXTRAOCULAR |
25
|
|
1851
|
FRACTION |
25
|
|
1852
|
HANSEN |
25
|
|
1853
|
IMPLANT |
25
|
|
1854
|
IMPROVES |
25
|
|
1855
|
IRRADIATED |
25
|
|
1856
|
LIMB |
25
|
|
1857
|
LUNGS |
25
|
|
1858
|
LYMPHADENOPATH+ |
25
|
|
1859
|
MAKE |
25
|
|
1860
|
MENINGIOMA |
25
|
|
1861
|
MV |
25
|
|
1862
|
NATURE |
25
|
|
1863
|
NEWER |
25
|
|
1864
|
NONINVASIVE |
25
|
|
1865
|
PARTY |
25
|
|
1866
|
PATHOLOGICALLY |
25
|
|
1867
|
PLASMACYTOMA |
25
|
|
1868
|
POLYCYTHEMIA |
25
|
|
1869
|
PREDICTOR |
25
|
|
1870
|
QUESTION |
25
|
|
1871
|
RADIOLOGIC |
25
|
|
1872
|
RADIOLOGY |
25
|
|
1873
|
RESECTIONS |
25
|
|
1874
|
SANDERS |
25
|
|
1875
|
TERMS |
25
|
|
1876
|
TESTS |
25
|
|
1877
|
VARIANT |
25
|
|
1878
|
ADENOMAS |
24
|
|
1879
|
APPARENT |
24
|
|
1880
|
BECOME |
24
|
|
1881
|
BLEEDING |
24
|
|
1882
|
BMT |
24
|
|
1883
|
CALLED |
24
|
|
1884
|
CARDIAC |
24
|
|
1885
|
CATEGORY |
24
|
|
1886
|
CHAIN |
24
|
|
1887
|
CHLORAMBUCIL |
24
|
|
1888
|
CIS |
24
|
|
1889
|
CLASSIC |
24
|
|
1890
|
CONSISTING |
24
|
|
1891
|
CONTENT |
24
|
|
1892
|
COST |
24
|
|
1893
|
DECISIONS |
24
|
|
1894
|
DIRECT |
24
|
|
1895
|
DONALDSON |
24
|
|
1896
|
EORTC |
24
|
|
1897
|
EPIDEMIOLOGY |
24
|
|
1898
|
EXENTERATION |
24
|
|
1899
|
FAST |
24
|
|
1900
|
FIBROUS |
24
|
|
1901
|
FOCAL |
24
|
|
1902
|
GALLIUM |
24
|
|
1903
|
GASTRECTOMY |
24
|
|
1904
|
GERSHENSON |
24
|
|
1905
|
HOPPE |
24
|
|
1906
|
HYPOPHARYNX |
24
|
|
1907
|
KAPLAN |
24
|
|
1908
|
LARYNGECTOMY |
24
|
|
1909
|
LD |
24
|
|
1910
|
LENGTH |
24
|
|
1911
|
LEUKEMIC |
24
|
|
1912
|
LONGO |
24
|
|
1913
|
LYNCH |
24
|
|
1914
|
MB |
24
|
|
1915
|
MORPHOLOGY |
24
|
|
1916
|
MULTIAGENT |
24
|
|
1917
|
OROPHARYNX |
24
|
|
1918
|
PATHOLOGIST |
24
|
|
1919
|
PERCENTAGE |
24
|
|
1920
|
PERIAORTIC |
24
|
|
1921
|
PILOT |
24
|
|
1922
|
PINEOBLASTOMA |
24
|
|
1923
|
PLEXUS |
24
|
|
1924
|
POLLACK |
24
|
|
1925
|
PROVIDED |
24
|
|
1926
|
PURE |
24
|
|
1927
|
RESPONSIVE |
24
|
|
1928
|
SECRETING |
24
|
|
1929
|
SEROUS |
24
|
|
1930
|
SMALLER |
24
|
|
1931
|
SOMATOSTATIN |
24
|
|
1932
|
SPACE |
24
|
|
1933
|
SUBGROUP |
24
|
|
1934
|
ACCURATELY |
23
|
|
1935
|
ANALOGUE |
23
|
|
1936
|
APPLIED |
23
|
|
1937
|
ASSIGNED |
23
|
|
1938
|
BACILLUS |
23
|
|
1939
|
BEHAVIOR |
23
|
|
1940
|
CHROMOSOMES |
23
|
|
1941
|
COMPANY |
23
|
|
1942
|
CORTICAL |
23
|
|
1943
|
DES |
23
|
|
1944
|
EDWARDS |
23
|
|
1945
|
ELIGIBLE |
23
|
|
1946
|
EPITHELIUM |
23
|
|
1947
|
ESTIMATED |
23
|
|
1948
|
FORASTIERE |
23
|
|
1949
|
GA |
23
|
|
1950
|
GW |
23
|
|
1951
|
HISTOPATHOLOGY |
23
|
|
1952
|
IRIS |
23
|
|
1953
|
KA |
23
|
|
1954
|
KJ |
23
|
|
1955
|
LAPAROSCOPIC |
23
|
|
1956
|
LEIOMYOSARCOMA |
23
|
|
1957
|
LISTING |
23
|
|
1958
|
LJ |
23
|
|
1959
|
MACROGLOBULINE+ |
23
|
|
1960
|
MAYO |
23
|
|
1961
|
MEASURES |
23
|
|
1962
|
MICROSCOPY |
23
|
|
1963
|
MILLER |
23
|
|
1964
|
MONTHLY |
23
|
|
1965
|
NEARLY |
23
|
|
1966
|
NODULES |
23
|
|
1967
|
NONLYMPHOCYTIC |
23
|
|
1968
|
NONSEMINOMA |
23
|
|
1969
|
NOR |
23
|
|
1970
|
OTHERWISE |
23
|
|
1971
|
PROBABILITY |
23
|
|
1972
|
PRODUCTION |
23
|
|
1973
|
PROPRIA |
23
|
|
1974
|
SEGMENTAL |
23
|
|
1975
|
SPECIFICALLY |
23
|
|
1976
|
SPLENOMEGALY |
23
|
|
1977
|
SR |
23
|
|
1978
|
SUPPRESSION |
23
|
|
1979
|
SURVIVE |
23
|
|
1980
|
TECHNICALLY |
23
|
|
1981
|
TF |
23
|
|
1982
|
TOGETHER |
23
|
|
1983
|
TOO |
23
|
|
1984
|
TRANSFORMATION |
23
|
|
1985
|
UNUSUAL |
23
|
|
1986
|
WANG |
23
|
|
1987
|
WEIGHT |
23
|
|
1988
|
WG |
23
|
|
1989
|
AB |
22
|
|
1990
|
ACCURATE |
22
|
|
1991
|
AH |
22
|
|
1992
|
ANTI |
22
|
|
1993
|
ANTICIPATED |
22
|
|
1994
|
APL |
22
|
|
1995
|
ASPARAGINASE |
22
|
|
1996
|
ASSESS |
22
|
|
1997
|
BENEFICIAL |
22
|
|
1998
|
BM |
22
|
|
1999
|
BR |
22
|
|
2000
|
BUSULFAN |
22
|
|
2001
|
CAIRO |
22
|
|
2002
|
CAVA |
22
|
|
2003
|
CLEAVED |
22
|
|
2004
|
CONSERVING |
22
|
|
2005
|
CPT |
22
|
|
2006
|
CYTOREDUCTION |
22
|
|
2007
|
DAVIS |
22
|
|
2008
|
DEHYDROGENASE |
22
|
|
2009
|
DER |
22
|
|
2010
|
EM |
22
|
|
2011
|
FLOW |
22
|
|
2012
|
GONADAL |
22
|
|
2013
|
HARD |
22
|
|
2014
|
HONG |
22
|
|
2015
|
INDIVIDUALIZED |
22
|
|
2016
|
ISSUES |
22
|
|
2017
|
JOHN |
22
|
|
2018
|
JUDE |
22
|
|
2019
|
KM |
22
|
|
2020
|
KRISCHER |
22
|
|
2021
|
MEASURED |
22
|
|
2022
|
MITOXANTRONE |
22
|
|
2023
|
MODEST |
22
|
|
2024
|
MODIFIERS |
22
|
|
2025
|
MULTIMODALITY |
22
|
|
2026
|
OBTAIN |
22
|
|
2027
|
PAROTID |
22
|
|
2028
|
PNET |
22
|
|
2029
|
RARITY |
22
|
|
2030
|
REASON |
22
|
|
2031
|
REMAIN |
22
|
|
2032
|
SEER |
22
|
|
2033
|
SEQUELAE |
22
|
|
2034
|
SHIELDS |
22
|
|
2035
|
SPRINGER |
22
|
|
2036
|
TE |
22
|
|
2037
|
TEND |
22
|
|
2038
|
THYROIDECTOMY |
22
|
|
2039
|
TM |
22
|
|
2040
|
TRANSFUSION |
22
|
|
2041
|
TWICE |
22
|
|
2042
|
URINE |
22
|
|
2043
|
VERLAG |
22
|
|
2044
|
VOCAL |
22
|
|
2045
|
WIERNIK |
22
|
|
2046
|
WONG |
22
|
|
2047
|
ACCOUNT |
21
|
|
2048
|
ADVANCES |
21
|
|
2049
|
APPROPRIATELY |
21
|
|
2050
|
ASCITES |
21
|
|
2051
|
ASPIRATION |
21
|
|
2052
|
AVERAGE |
21
|
|
2053
|
AW |
21
|
|
2054
|
BULK |
21
|
|
2055
|
BYPASS |
21
|
|
2056
|
CHANG |
21
|
|
2057
|
CONSIDER |
21
|
|
2058
|
CONSIDERABLE |
21
|
|
2059
|
CONTIGUOUS |
21
|
|
2060
|
COSMETIC |
21
|
|
2061
|
CREATED |
21
|
|
2062
|
DEFICIENCY |
21
|
|
2063
|
DISSEMINATION |
21
|
|
2064
|
DISTINGUISH |
21
|
|
2065
|
DUCTAL |
21
|
|
2066
|
EXTREMELY |
21
|
|
2067
|
FB |
21
|
|
2068
|
FH |
21
|
|
2069
|
GINGIVA |
21
|
|
2070
|
GLADER |
21
|
|
2071
|
GRIGSBY |
21
|
|
2072
|
HIGHEST |
21
|
|
2073
|
INCREASES |
21
|
|
2074
|
INFLUENCING |
21
|
|
2075
|
INFRATENTORIAL |
21
|
|
2076
|
INSTITUTIONAL |
21
|
|
2077
|
INTERVENTION |
21
|
|
2078
|
JK |
21
|
|
2079
|
KR |
21
|
|
2080
|
LC |
21
|
|
2081
|
LDH |
21
|
|
2082
|
LEFT |
21
|
|
2083
|
LYMPHOPROLIFER+ |
21
|
|
2084
|
MEDIUM |
21
|
|
2085
|
MERCAPTOPURINE |
21
|
|
2086
|
MODERN |
21
|
|
2087
|
MOHS |
21
|
|
2088
|
OPPORTUNISTIC |
21
|
|
2089
|
PAJAK |
21
|
|
2090
|
PD |
21
|
|
2091
|
PHOTON |
21
|
|
2092
|
PLEURA |
21
|
|
2093
|
PRESENTATIONS |
21
|
|
2094
|
PRESS |
21
|
|
2095
|
PROVIDES |
21
|
|
2096
|
RECUR |
21
|
|
2097
|
REMAINING |
21
|
|
2098
|
RESULTING |
21
|
|
2099
|
ROTH |
21
|
|
2100
|
SHOWS |
21
|
|
2101
|
SPECIMEN |
21
|
|
2102
|
SPECIMENS |
21
|
|
2103
|
SPORADIC |
21
|
|
2104
|
SUPRASELLAR |
21
|
|
2105
|
THOUGHT |
21
|
|
2106
|
UROTHELIAL |
21
|
|
2107
|
VP |
21
|
|
2108
|
VULVECTOMY |
21
|
|
2109
|
ACCEPTABLE |
20
|
|
2110
|
AMOUNT |
20
|
|
2111
|
ANATOMIC |
20
|
|
2112
|
BG |
20
|
|
2113
|
BHCG |
20
|
|
2114
|
BIOPSIES |
20
|
|
2115
|
BOOST |
20
|
|
2116
|
BOYS |
20
|
|
2117
|
CANADA |
20
|
|
2118
|
CARRY |
20
|
|
2119
|
CHANCE |
20
|
|
2120
|
CLINICIANS |
20
|
|
2121
|
COHORT |
20
|
|
2122
|
CONTROVERSY |
20
|
|
2123
|
CRANIOSPINAL |
20
|
|
2124
|
CW |
20
|
|
2125
|
DESCRIPTION |
20
|
|
2126
|
DESTRUCTION |
20
|
|
2127
|
DETERMINATION |
20
|
|
2128
|
DETERMINING |
20
|
|
2129
|
EFFECTIVELY |
20
|
|
2130
|
ENDOMETRIUM |
20
|
|
2131
|
FLEMING |
20
|
|
2132
|
GERMINOMA |
20
|
|
2133
|
GH |
20
|
|
2134
|
HH |
20
|
|
2135
|
HO |
20
|
|
2136
|
HYPERCALCEMIA |
20
|
|
2137
|
IMMUNOLOGIC |
20
|
|
2138
|
IMPROVING |
20
|
|
2139
|
ITALIAN |
20
|
|
2140
|
KC |
20
|
|
2141
|
KRAILO |
20
|
|
2142
|
LHRH |
20
|
|
2143
|
MARTIN |
20
|
|
2144
|
MITOTIC |
20
|
|
2145
|
MK |
20
|
|
2146
|
MOORE |
20
|
|
2147
|
MUCINOUS |
20
|
|
2148
|
NY |
20
|
|
2149
|
OCULAR |
20
|
|
2150
|
OPTIMUM |
20
|
|
2151
|
PF |
20
|
|
2152
|
PLANNED |
20
|
|
2153
|
PLAQUE |
20
|
|
2154
|
POSSIBILITY |
20
|
|
2155
|
PROBABLY |
20
|
|
2156
|
PROCARBAZINE |
20
|
|
2157
|
PROGNOSES |
20
|
|
2158
|
PROGRESSING |
20
|
|
2159
|
PROLONGATION |
20
|
|
2160
|
PROPOSED |
20
|
|
2161
|
RECOGNIZED |
20
|
|
2162
|
REGRESSION |
20
|
|
2163
|
RELIEF |
20
|
|
2164
|
REVISED |
20
|
|
2165
|
SOMEWHAT |
20
|
|
2166
|
TP |
20
|
|
2167
|
TRADITIONAL |
20
|
|
2168
|
TUR |
20
|
|
2169
|
TW |
20
|
|
2170
|
VARIES |
20
|
|
2171
|
VCR |
20
|
|
2172
|
WAY |
20
|
|
2173
|
WIEAND |
20
|
|
2174
|
ABSTRACT |
19
|
|
2175
|
ACHIEVING |
19
|
|
2176
|
AD |
19
|
|
2177
|
ALCOHOL |
19
|
|
2178
|
ANAPLASIA |
19
|
|
2179
|
ANTHRACYCLINE |
19
|
|
2180
|
ANTICANCER |
19
|
|
2181
|
AVOIDED |
19
|
|
2182
|
BLASTIC |
19
|
|
2183
|
BURGER |
19
|
|
2184
|
CCNU |
19
|
|
2185
|
CHALLENGE |
19
|
|
2186
|
COMPLETED |
19
|
|
2187
|
CONSERVATION |
19
|
|
2188
|
CORRELATE |
19
|
|
2189
|
CORVO |
19
|
|
2190
|
COULD |
19
|
|
2191
|
CTCL |
19
|
|
2192
|
CYSTIC |
19
|
|
2193
|
DEFERRED |
19
|
|
2194
|
DEFINE |
19
|
|
2195
|
DESIGN |
19
|
|
2196
|
DISTRIBUTION |
19
|
|
2197
|
DUFFNER |
19
|
|
2198
|
ELEVATION |
19
|
|
2199
|
ENTITIES |
19
|
|
2200
|
EP |
19
|
|
2201
|
ETB |
19
|
|
2202
|
ETHMOID |
19
|
|
2203
|
GENITAL |
19
|
|
2204
|
GRECO |
19
|
|
2205
|
HB |
19
|
|
2206
|
HEPATOMA |
19
|
|
2207
|
INFLUENCED |
19
|
|
2208
|
INTRINSIC |
19
|
|
2209
|
KEMENY |
19
|
|
2210
|
KINGDOM |
19
|
|
2211
|
LANGE |
19
|
|
2212
|
LL |
19
|
|
2213
|
LOCALIZATION |
19
|
|
2214
|
LR |
19
|
|
2215
|
MAXILLARY |
19
|
|
2216
|
MAXIMAL |
19
|
|
2217
|
MCGUIRE |
19
|
|
2218
|
MONTH |
19
|
|
2219
|
MORRIS |
19
|
|
2220
|
NEITHER |
19
|
|
2221
|
OFFERED |
19
|
|
2222
|
OPEN |
19
|
|
2223
|
ORBITAL |
19
|
|
2224
|
ORTEGA |
19
|
|
2225
|
OXALIPLATIN |
19
|
|
2226
|
OXFORD |
19
|
|
2227
|
PAPILLOMA |
19
|
|
2228
|
PARAMETERS |
19
|
|
2229
|
PARTICIPATION |
19
|
|
2230
|
PAST |
19
|
|
2231
|
PIZZO |
19
|
|
2232
|
POSTMENOPAUSAL |
19
|
|
2233
|
POSTOPERATIVEL+ |
19
|
|
2234
|
PREGNANT |
19
|
|
2235
|
PREOPERATIVELY |
19
|
|
2236
|
PRODUCES |
19
|
|
2237
|
PRODUCING |
19
|
|
2238
|
PROLONG |
19
|
|
2239
|
PYRIFORM |
19
|
|
2240
|
RANEY |
19
|
|
2241
|
RECOMMENDATION+ |
19
|
|
2242
|
REVIEWS |
19
|
|
2243
|
SATHER |
19
|
|
2244
|
SEXUAL |
19
|
|
2245
|
SHAPIRO |
19
|
|
2246
|
SIMILARLY |
19
|
|
2247
|
SIMPLE |
19
|
|
2248
|
SPECTRUM |
19
|
|
2249
|
SUSPECTED |
19
|
|
2250
|
THROUGHOUT |
19
|
|
2251
|
UNCERTAIN |
19
|
|
2252
|
UNLESS |
19
|
|
2253
|
USUAL |
19
|
|
2254
|
VARYING |
19
|
|
2255
|
WIDESPREAD |
19
|
|
2256
|
WRIGHT |
19
|
|
2257
|
ACTUARIAL |
18
|
|
2258
|
ARTERY |
18
|
|
2259
|
BD |
18
|
|
2260
|
CARCINOIDS |
18
|
|
2261
|
CD |
18
|
|
2262
|
CDDP |
18
|
|
2263
|
CHARACTERISTIC |
18
|
|
2264
|
CILIARY |
18
|
|
2265
|
CIRCULATING |
18
|
|
2266
|
CIRRHOSIS |
18
|
|
2267
|
COMPLEX |
18
|
|
2268
|
CONDITION |
18
|
|
2269
|
CONTRAINDICATI+ |
18
|
|
2270
|
CRISIS |
18
|
|
2271
|
CRIST |
18
|
|
2272
|
CYTOREDUCTIVE |
18
|
|
2273
|
DERIVED |
18
|
|
2274
|
DIVERSION |
18
|
|
2275
|
EARLIER |
18
|
|
2276
|
EFFUSION |
18
|
|
2277
|
EQUALLY |
18
|
|
2278
|
EXTRA |
18
|
|
2279
|
FAR |
18
|
|
2280
|
FLOOR |
18
|
|
2281
|
FOWLER |
18
|
|
2282
|
FRACTIONATION |
18
|
|
2283
|
FULGURATION |
18
|
|
2284
|
FULL |
18
|
|
2285
|
GAYNON |
18
|
|
2286
|
GOLDBERG |
18
|
|
2287
|
GOLDWEIN |
18
|
|
2288
|
GROSSLY |
18
|
|
2289
|
HEPATITIS |
18
|
|
2290
|
HERR |
18
|
|
2291
|
HISTIOCYTOMA |
18
|
|
2292
|
HODGKIN |
18
|
|
2293
|
HOFFMAN |
18
|
|
2294
|
HOST |
18
|
|
2295
|
IDARUBICIN |
18
|
|
2296
|
IFN |
18
|
|
2297
|
INCOMPLETE |
18
|
|
2298
|
INDICATES |
18
|
|
2299
|
INFILTRATION |
18
|
|
2300
|
INJECTION |
18
|
|
2301
|
JONES |
18
|
|
2302
|
KEATING |
18
|
|
2303
|
KIM |
18
|
|
2304
|
KK |
18
|
|
2305
|
LAWRENCE |
18
|
|
2306
|
MEDIASTINUM |
18
|
|
2307
|
MERLANO |
18
|
|
2308
|
MOUTH |
18
|
|
2309
|
NEUROFIBROMATO+ |
18
|
|
2310
|
NEURONAL |
18
|
|
2311
|
NICHOLS |
18
|
|
2312
|
NONFUNCTIONING |
18
|
|
2313
|
NOVO |
18
|
|
2314
|
OBVIATE |
18
|
|
2315
|
ORBIT |
18
|
|
2316
|
PAPPO |
18
|
|
2317
|
PERCENT |
18
|
|
2318
|
PREDOMINANTLY |
18
|
|
2319
|
PRESENTS |
18
|
|
2320
|
PUI |
18
|
|
2321
|
RADIOGRAPHIC |
18
|
|
2322
|
RANGING |
18
|
|
2323
|
RAO |
18
|
|
2324
|
RAYS |
18
|
|
2325
|
RECOGNITION |
18
|
|
2326
|
RED |
18
|
|
2327
|
RF |
18
|
|
2328
|
RODRIGUEZ |
18
|
|
2329
|
SANTORO |
18
|
|
2330
|
SCANNING |
18
|
|
2331
|
SELECT |
18
|
|
2332
|
SEX |
18
|
|
2333
|
SIX |
18
|
|
2334
|
SPINE |
18
|
|
2335
|
STRONGLY |
18
|
|
2336
|
SWOG |
18
|
|
2337
|
UNDERLYING |
18
|
|
2338
|
UNEXPLAINED |
18
|
|
2339
|
UNIQUE |
18
|
|
2340
|
UPTAKE |
18
|
|
2341
|
UROLOGIC |
18
|
|
2342
|
VAST |
18
|
|
2343
|
WAITING |
18
|
|
2344
|
WHAT |
18
|
|
2345
|
WIDELY |
18
|
|
2346
|
ZHANG |
18
|
|
2347
|
ACCOUNTS |
17
|
|
2348
|
ADD |
17
|
|
2349
|
AFFECTED |
17
|
|
2350
|
AID |
17
|
|
2351
|
ANDERSEN |
17
|
|
2352
|
ARABINOSIDE |
17
|
|
2353
|
BARRETT |
17
|
|
2354
|
BCR |
17
|
|
2355
|
BONES |
17
|
|
2356
|
CHAN |
17
|
|
2357
|
CHANGE |
17
|
|
2358
|
CLONAL |
17
|
|
2359
|
COGNITIVE |
17
|
|
2360
|
COLLEGE |
17
|
|
2361
|
CONTAIN |
17
|
|
2362
|
CUMULATIVE |
17
|
|
2363
|
CYTOSINE |
17
|
|
2364
|
DD |
17
|
|
2365
|
DEATHS |
17
|
|
2366
|
DIE |
17
|
|
2367
|
DISORDER |
17
|
|
2368
|
DOUBLE |
17
|
|
2369
|
ELECTIVE |
17
|
|
2370
|
ENDOSCOPY |
17
|
|
2371
|
ERYTHROPOIETIN |
17
|
|
2372
|
EVENTUALLY |
17
|
|
2373
|
FETAL |
17
|
|
2374
|
FETOPROTEIN |
17
|
|
2375
|
GENERALIZED |
17
|
|
2376
|
GENES |
17
|
|
2377
|
GERMLINE |
17
|
|
2378
|
GLOTTIC |
17
|
|
2379
|
GLYCOPROTEIN |
17
|
|
2380
|
GOLDMAN |
17
|
|
2381
|
GRADING |
17
|
|
2382
|
HAYS |
17
|
|
2383
|
HEREDITARY |
17
|
|
2384
|
HISTOLOGICAL |
17
|
|
2385
|
HW |
17
|
|
2386
|
IDENTIFYING |
17
|
|
2387
|
INC |
17
|
|
2388
|
INFANTILE |
17
|
|
2389
|
INFILTRATING |
17
|
|
2390
|
JUNCTION |
17
|
|
2391
|
LARAMORE |
17
|
|
2392
|
LARGELY |
17
|
|
2393
|
LATERAL |
17
|
|
2394
|
LIPOSOMAL |
17
|
|
2395
|
LIPPMAN |
17
|
|
2396
|
LISTED |
17
|
|
2397
|
LOBE |
17
|
|
2398
|
MEASURABLE |
17
|
|
2399
|
MEDICALLY |
17
|
|
2400
|
MINORITY |
17
|
|
2401
|
MULTICENTRIC |
17
|
|
2402
|
MUSCULARIS |
17
|
|
2403
|
NA |
17
|
|
2404
|
NEUROLOGY |
17
|
|
2405
|
NEVER |
17
|
|
2406
|
NOVEL |
17
|
|
2407
|
O'BRIEN |
17
|
|
2408
|
OROPHARYNGEAL |
17
|
|
2409
|
OUTPATIENT |
17
|
|
2410
|
PAULSON |
17
|
|
2411
|
PERIODIC |
17
|
|
2412
|
PHYSICIANS |
17
|
|
2413
|
POPLACK |
17
|
|
2414
|
PREDICTS |
17
|
|
2415
|
RANGES |
17
|
|
2416
|
RECURS |
17
|
|
2417
|
REPEATED |
17
|
|
2418
|
RESPONDERS |
17
|
|
2419
|
RESPONDING |
17
|
|
2420
|
REVEALED |
17
|
|
2421
|
SAC |
17
|
|
2422
|
SARRAF |
17
|
|
2423
|
SCHEITHAUER |
17
|
|
2424
|
SITUATIONS |
17
|
|
2425
|
SKINNER |
17
|
|
2426
|
TAKEN |
17
|
|
2427
|
TENDENCY |
17
|
|
2428
|
THROMBOCYTHEMI+ |
17
|
|
2429
|
TIMING |
17
|
|
2430
|
TRANS |
17
|
|
2431
|
UNCLEAR |
17
|
|
2432
|
VIEW |
17
|
|
2433
|
YOLK |
17
|
|
2434
|
ACCURACY |
16
|
|
2435
|
ADJUNCTIVE |
16
|
|
2436
|
AGNOGENIC |
16
|
|
2437
|
ALBRIGHT |
16
|
|
2438
|
ANNUAL |
16
|
Índice general I Índice Apéndice II I Siguiente
| ISSN: 1139-8736 Depósito Legal: B-37271-2002 Copyright: © Silvia Montero Martínez |